Science leaders

Our science and commercialisation leaders have diverse backgrounds but together provide a wealth of expertise for clients and collaborators.

A profile image of Richard Furneaux.

Professor Richard Furneaux

As Institute Director, Richard leads the team, influences its research direction, protects its IP and keeps in touch with collaborators and clients worldwide.

A profile image of Gary Evans.

Professor Gary Evans

Gary enjoys organic synthesis, medicinal and process chemistry. Creating new enzyme inhibitors, like the potent DADMe-Immucillins, are career highlights.

A profile image of Peter Tyler.

Professor Peter Tyler

Peter leads the enzyme inhibitor and heparan sulfate synthesis research programmes and manages the team’s key collaborations.

A profile image of Phillip Rendle.

Dr Phillip Rendle

Phill manages the custom synthesis, scale-up and process development work, linking to GlycoSyn’s cGMP facility. He researches dendrimers for pharmaceutical use.

Photograph of Gavin Painter sitting with a microscope in a lab.

Professor Gavin Painter

Gavin leads research in the design and synthesis of drugs, vaccines and immunotherapeutics. One focus is cancer immunotherapy, with the Malaghan Institute.

A profile image of Simon Hinkley.

Dr Simon Hinkley

Simon has a passion to work with industry’s real-world chemical problems using his skill base in natural products, polymer science and cGMP drug manufacture.

Professor Emily Parker in her lab

Professor Emily Parker

Emily leads a research group that is applying synthetic biology to aid in the development of new treatments for disease.

Lawrence Harris outside lab

Dr Lawrence Harris

Lawrence is a synthetic organic chemist with a research focus on developing enzyme inhibitors and synthetic methodologies in organic chemistry.